Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 18 of 18 publications.

Yubin Sohn A, Khanji C, Nuabor W, Gould T, Kim HK, Barrows SM, Herbel B, Njue A. Effect of adherence to hemophilia drug therapy on outcomes: a systematic literature review. Poster to be given at the ISPOR Europe 2024; November 17, 2024. Barcelona, Spain.

Khan S, Mordin M, Barrows SB, Copley-Merriman K. Similarities & differences in Global Value Dossier (GVD) and Academy of Managed Care Pharmacy (AMCP) dossier development. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 22, 2019. New Orleans, LA.

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET. Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer. Lung Cancer. 2019 Feb 8;2019:11-20. doi: 10.2147/LCTT.S179349

Barrows SM, Cai B, Copley-Merriman C, Wright KR, Castro CV, Soufi-Mahjoubi R. Systematic literature review of the antitumor effect of octreotide in neuroendocrine tumors. World J Meta-Anal. 2018 Jun 28;6(2):9-20.

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET. Systematic Literature Review (SLR) of sequencing of Anaplastic Lymphoma Kinase (ALK) inhibitors in ALK-Positive Non-Small Cell Lung Cancer (NSCLC). Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 22, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S49-50. doi: 10.1016/j.jval.2018.04.291

Barrows SM, Cai B, Wright K, Castro CV, Kaye JA, Copley-Merriman C, Soufi-Mahjoubi R. Systematic literature review of octreotide's antitumor effects in neuroendocrine tumors. Poster presented at the 2017 North American Neuroendocrine Tumor Society Annual Symposium; October 19, 2017. Philadelphia, PA.

Edson-Heredia E, Barrows S, Masaquel C, Nikai E, Mallbris L, Puig L. The value of achieving complete or near complete resolution of psoriasis. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Copley-Merriman C, Zelt S, Stone G, Barrows SM, Mordin MM, Hogue SL. Emerging-market payer needs: how should these countries be included in dermatology drug development plans? Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014.

Mordin M, Hogue S, Barrows S, van Amerongen D. Safe and effective versus reasonable and necessary: is the deck stacked against medical devices? Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 30, 2013. [abstract] Value Health. 2013 May; 16(3):246.

Copley-Merriman K, Barrows SM, Whiteley J, Barrett AM. Value messages: developing, incorporating, and making use of a core strategic tool. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 28, 2009.

Copley-Merriman K, Barrett AM, Barrows SM, Whiteley J. Understanding and transmitting the value of a new drug. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009.

Harness J, Mamolo C, Olsen E, Price V, DeMuro-Mercon CJ, Fehnel SE, Barrows SM. The women's hair growth questionnaire (WHGQ): development and validation of a patient-reported measure for treatment efficacy in female pattern alopecia. Poster presented at the 67th Annual Meeting of the American Academy of Dermatology; March 2009.

Colman S, Barrows SM, Nixon A, Nixon M, Taylor T, Atkinson M, Miller T. Validation of the hyperpigmentation treatment satisfaction questionnaire (HPTSQ). Presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.

Barrows SM, Colman SS, Nixon M, Nixon A, Taylor TN. Estimated prevalence of solar lentigines and melasma in the US population. Poster presented at the Annual Meeting of the American Academy of Dermatology; March 2006.

Williams V, Morlock R, Fehnel S, Wills MM, Hill CD, Barrows S, Cappelleri J, Feltner D. Development and evaluation of the daily assessment of symptoms–anxiety (DAS-A) scale for measurement of onset of symptom relief in patients with gad. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.

Colman SS, Nixon A, Barrows SM, Taylor TN, Miller T. Qualitative research methods: development of a hyperpigmentation treatment satisfaction with medication questionnaire. Poster presented at the Annual Meeting of the International Society for Quality of Life Research; October 2005.

Barrows SM, Brown MT. Effect of valdecoxib on functional impairment, quality of life and patient satisfaction in migraine patients. Poster presented at the Annual Meeting of the American College of Nurse Practitioners; October 2004.

Rowland CR, Barrows SM, Brown MT. Effects of valdecoxib on functional impairment, quality of life and treatment satisfaction in migraine patients. Poster presented at the Annual Meeting of the International Headache Society; September 2003.